Psychoactive Agents and Mental Disorders in Lone-Actor Terrorism

Michael Arieli; Aviv Weinstein; Uri Ben Yaakov; Ronnie Berkovitz; Alina Poperno; Hagit Bonny-Noach; Robert P. Granacher

doi:https://doi.org/10.1093/med/9780190929794.003.0005

Psychoactive Agents and Mental Disorders in Lone-Actor Terrorism

Michael Arieli, Aviv Weinstein, Uri Ben Yaakov, Ronnie Berkovitz, Alina Poperno, Hagit Bonny-Noach, Robert P. Granacher

Ariel University

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

This chapter reviews the impact of psychoactive substances, examining their physiological and psychological effects on lone-actor terrorism. Initially, it introduces the emerging concept of “pharmacoterrorism,” in both lone-actor and organized terror scenarios. The almost symbiotic relationship between mental illness and psychoactive substances can constitute a significant risk factor in the lone actor’s path to terror. The chapter then surveys, via case studies, the use by lone-actor terrorists of cannabis, stimulants, anabolic androgenic steroids (AAS), and alcohol, and the neuropsychiatric adverse effects attributable to mefloquine. It will then proceed to analyze the relationship between the psychoactive substance and the mental illnesses of the lone-actor terrorists. In conclusion, the chapter discusses the challenges and future areas of research on this topic.

Original language	English
Title of host publication	Lone-Actor Terrorism: An Integrated Framework
Place of Publication	Oxford, UK
Publisher	Oxford University Press
ISBN (Print)	9780190929824
DOIs	https://doi.org/10.1093/med/9780190929794.003.0005
State	Published - 2022

Access to Document

https://doi.org/10.1093/med/9780190929794.003.0005

https://oxfordmedicine.com/view/10.1093/med/9780190929794.001.0001/med-9780190929794-chapter-5

Cite this

@inbook{9f9e7230c10341bca06a5dc7218b9f5d,

title = "Psychoactive Agents and Mental Disorders in Lone-Actor Terrorism",

abstract = "This chapter reviews the impact of psychoactive substances, examining their physiological and psychological effects on lone-actor terrorism. Initially, it introduces the emerging concept of “pharmacoterrorism,” in both lone-actor and organized terror scenarios. The almost symbiotic relationship between mental illness and psychoactive substances can constitute a significant risk factor in the lone actor{\textquoteright}s path to terror. The chapter then surveys, via case studies, the use by lone-actor terrorists of cannabis, stimulants, anabolic androgenic steroids (AAS), and alcohol, and the neuropsychiatric adverse effects attributable to mefloquine. It will then proceed to analyze the relationship between the psychoactive substance and the mental illnesses of the lone-actor terrorists. In conclusion, the chapter discusses the challenges and future areas of research on this topic.",

author = "Michael Arieli and Aviv Weinstein and Yaakov, {Uri Ben} and Ronnie Berkovitz and Alina Poperno and Hagit Bonny-Noach and Granacher, {Robert P.}",

year = "2022",

doi = "https://doi.org/10.1093/med/9780190929794.003.0005",

language = "الإنجليزيّة",

isbn = "9780190929824",

booktitle = "Lone-Actor Terrorism: An Integrated Framework",

publisher = "Oxford University Press",

address = "الولايات المتّحدة",

}

TY - CHAP

T1 - Psychoactive Agents and Mental Disorders in Lone-Actor Terrorism

AU - Arieli, Michael

AU - Weinstein, Aviv

AU - Yaakov, Uri Ben

AU - Berkovitz, Ronnie

AU - Poperno, Alina

AU - Bonny-Noach, Hagit

AU - Granacher, Robert P.

PY - 2022

Y1 - 2022

N2 - This chapter reviews the impact of psychoactive substances, examining their physiological and psychological effects on lone-actor terrorism. Initially, it introduces the emerging concept of “pharmacoterrorism,” in both lone-actor and organized terror scenarios. The almost symbiotic relationship between mental illness and psychoactive substances can constitute a significant risk factor in the lone actor’s path to terror. The chapter then surveys, via case studies, the use by lone-actor terrorists of cannabis, stimulants, anabolic androgenic steroids (AAS), and alcohol, and the neuropsychiatric adverse effects attributable to mefloquine. It will then proceed to analyze the relationship between the psychoactive substance and the mental illnesses of the lone-actor terrorists. In conclusion, the chapter discusses the challenges and future areas of research on this topic.

AB - This chapter reviews the impact of psychoactive substances, examining their physiological and psychological effects on lone-actor terrorism. Initially, it introduces the emerging concept of “pharmacoterrorism,” in both lone-actor and organized terror scenarios. The almost symbiotic relationship between mental illness and psychoactive substances can constitute a significant risk factor in the lone actor’s path to terror. The chapter then surveys, via case studies, the use by lone-actor terrorists of cannabis, stimulants, anabolic androgenic steroids (AAS), and alcohol, and the neuropsychiatric adverse effects attributable to mefloquine. It will then proceed to analyze the relationship between the psychoactive substance and the mental illnesses of the lone-actor terrorists. In conclusion, the chapter discusses the challenges and future areas of research on this topic.

U2 - https://doi.org/10.1093/med/9780190929794.003.0005

DO - https://doi.org/10.1093/med/9780190929794.003.0005

M3 - فصل

SN - 9780190929824

BT - Lone-Actor Terrorism: An Integrated Framework

PB - Oxford University Press

CY - Oxford, UK

ER -

Psychoactive Agents and Mental Disorders in Lone-Actor Terrorism

Abstract

Access to Document

Fingerprint

Cite this